Cargando…
Prevalent p53 mutants co-opt chromatin pathways to drive cancer growth
TP53 is the most frequently mutated gene among all human cancers. Prevalent p53 missense mutations abrogate its tumor suppressive function and lead to “gain-of-function” (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the met...
Autores principales: | Zhu, Jiajun, Sammons, Morgan A., Donahue, Greg, Dou, Zhixun, Vedadi, Masoud, Getlik, Matthaeus, Barsyte-Lovejoy, Dalia, Al-Awar, Rima, Katona, Bryson W., Shilatifard, Ali, Huang, Jing, Hua, Xianxin, Arrowsmith, Cheryl H., Berger, Shelley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568559/ https://www.ncbi.nlm.nih.gov/pubmed/26331536 http://dx.doi.org/10.1038/nature15251 |
Ejemplares similares
-
Targeting human SET1/MLL family of proteins
por: Vedadi, Masoud, et al.
Publicado: (2017) -
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
por: Senisterra, Guillermo, et al.
Publicado: (2012) -
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
por: Grebien, Florian, et al.
Publicado: (2015) -
Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex
por: Ivanochko, Danton, et al.
Publicado: (2019) -
Structure and Function of Protein Arginine Methyltransferase PRMT7
por: Halabelian, Levon, et al.
Publicado: (2021)